ODYS

+ Watchlist + Portfolio

Odysight.ai Inc.

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.82
52-Week Range: $2.51 – $11.30
Market Cap: $56.89M
P/E (TTM): —
EPS (TTM): -1.10
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 2.71
PEG Ratio: —
Return on Equity: -72.81%
Return on Assets: -41.01%
Gross Margin: 34.86%
Operating Margin: -1078.81%
Profit Margin: 0.00%
Current Ratio: 5.82
Debt/Equity: 0.05
Total Debt: $834.00K
Free Cash Flow: $-9.36M
Revenue Growth: 16.00%
Earnings Growth: —
Enterprise Value: $30.51M

ODYS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$665.00K	$3.03M	$3.96M	$3.02M
Cost of Revenue	$1.63M	$2.52M	$2.81M	$2.14M
Gross Profit	-$966.00K	$509.00K	$1.16M	$871.00K
Research & Development	$4.52M	$6.27M	$7.34M	$10.70M
Selling, General & Admin	$4.05M	$4.82M	$6.30M	$8.29M
Operating Expenses	$8.47M	$11.14M	$13.66M	$19.01M
Operating Income	-$9.44M	-$10.63M	-$12.51M	-$18.14M
EBITDA	-$9.19M	-$10.35M	-$12.38M	-$18.02M
Pretax Income	-$9.47M	-$9.45M	-$11.77M	-$17.04M
Income Tax	$0.00	$0.00	$0.00	—
Net Income	-$9.47M	-$9.45M	-$11.77M	-$17.04M
Diluted EPS	-1.33	-0.98	-1.03	-1.07
Diluted Shares	7.12M	9.67M	11.45M	15.90M

ODYS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$10.10M	$8.95M	$18.16M	$25.68M
Receivables	$60.00K	$1.37M	$1.51M	$278.00K
Inventory	$630.00K	$504.00K	$203.00K	$50.00K
Current Assets	$14.12M	$19.35M	$20.79M	$27.50M
Total Assets	$16.89M	$22.83M	$23.68M	$28.98M
Current Liabilities	$2.56M	$2.08M	$3.29M	$3.00M
Total Debt	$263.00K	$1.33M	$1.05M	$770.00K
Total Liabilities	$5.11M	$5.02M	$5.43M	$3.55M
Retained Earnings	-$24.76M	-$34.21M	-$45.97M	-$63.01M
Shareholders' Equity	$11.79M	$17.81M	$18.24M	$25.43M
Working Capital	$11.56M	$17.27M	$17.49M	$24.50M

ODYS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$6.09M	-$10.01M	-$8.22M	-$13.70M
Capital Expenditure	-$118.00K	-$113.00K	-$53.00K	-$56.00K
Free Cash Flow	-$6.21M	-$10.12M	-$8.27M	-$13.76M
Depreciation & Amortisation	$251.00K	$284.00K	$123.00K	$117.00K
Stock-Based Compensation	$1.64M	$1.66M	$2.39M	$3.08M
Investing Cash Flow	$7.88M	-$5.11M	$7.64M	$254.00K
Financing Cash Flow	$0.00	$13.81M	$9.82M	$21.14M
Net Change in Cash	$1.79M	-$1.31M	$9.24M	$7.69M

ODYS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$2.06M	$362.00K	$149.00K	$439.00K	$82.00K	$420.00K
Cost of Revenue	$1.53M	$229.00K	$126.00K	$262.00K	$61.00K	$261.00K
Gross Profit	$538.00K	$133.00K	$23.00K	$177.00K	$21.00K	$159.00K
Research & Development	$2.49M	$2.36M	$2.48M	$3.38M	$2.56M	$2.24M
Selling, General & Admin	$2.61M	$2.21M	$2.25M	$1.21M	$2.80M	$2.45M
Operating Expenses	$5.10M	$4.57M	$4.73M	$4.61M	$5.36M	$4.69M
Operating Income	-$4.56M	-$4.44M	-$4.71M	-$4.43M	-$5.34M	-$4.53M
EBITDA	-$4.53M	-$4.41M	-$4.68M	-$4.40M	-$5.31M	-$4.50M
Pretax Income	-$4.26M	-$4.08M	-$4.42M	-$4.28M	-$5.18M	-$4.32M
Net Income	-$4.26M	-$4.08M	-$4.42M	-$4.28M	-$5.18M	-$4.32M
Diluted EPS	-0.29	-0.25	-0.27	—	-0.32	-0.26
Diluted Shares	14.57M	16.32M	16.33M	—	16.39M	16.79M

ODYS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$36.88M	$32.91M	$29.48M	$25.68M	$21.76M	$17.22M
Receivables	$192.00K	$509.00K	$354.00K	$278.00K	$104.00K	$677.00K
Inventory	$0.00	$0.00	$0.00	$50.00K	$313.00K	$244.00K
Current Assets	$38.09M	$34.88M	$31.34M	$27.50M	$22.63M	$19.23M
Total Assets	$39.84M	$36.56M	$32.91M	$28.98M	$24.64M	$21.38M
Current Liabilities	$3.42M	$3.29M	$3.21M	$3.00M	$2.98M	$3.42M
Total Debt	$911.00K	$919.00K	$844.00K	$770.00K	$663.00K	$834.00K
Total Liabilities	$4.08M	$3.96M	$3.80M	$3.55M	$3.48M	$3.99M
Retained Earnings	-$50.24M	-$54.31M	-$58.73M	-$63.01M	-$68.19M	-$72.51M
Shareholders' Equity	$35.77M	$32.60M	$29.11M	$25.43M	$21.16M	$17.39M
Working Capital	$34.67M	$31.59M	$28.13M	$24.50M	$19.65M	$15.80M

ODYS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$2.23M	-$4.17M	-$3.42M	-$3.88M	-$4.25M	-$4.46M
Capital Expenditure	-$27.00K	-$3.00K	-$11.00K	-$15.00K	-$6.00K	-$28.00K
Free Cash Flow	-$2.26M	-$4.17M	-$3.43M	-$3.90M	-$4.26M	-$4.49M
Depreciation & Amortisation	$27.00K	$31.00K	$30.00K	$29.00K	$27.00K	$29.00K
Stock-Based Compensation	$806.00K	$845.00K	$914.00K	$513.00K	$886.00K	$452.00K
Investing Cash Flow	$283.00K	-$3.00K	-$11.00K	-$15.00K	-$6.00K	-$337.00K
Financing Cash Flow	$21.02M	$34.00K	$1.00K	$82.00K	$32.00K	$101.00K
Share Repurchases	—	-$35.00K	-$7.00K	—	—	—
Net Change in Cash	$19.07M	-$4.14M	-$3.43M	-$3.81M	-$4.23M	-$4.70M

Market Snapshot

About

Medical technology company developing AI-powered visual monitoring solutions for healthcare settings. The platform uses computer vision and machine learning to continuously monitor patients, enabling early detection of deterioration and improving patient safety in hospitals and care facilities.